Martin D Madaus is a director of Quanterix Corp.
Person profile
Roles
Address
Billerica, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | QTRX Quanterix | Common Stock | Grant | Acquire A | No | No | 0 | 2,947 | 0.00 | 29,473 |
2 Jan 24 | QTRX Quanterix | Stock Option Common Stock | Grant | Acquire A | No | No | 27.15 | 6,412 | 174.09 k | 6,412 |
20 Oct 23 | LAB Standard BioTools | Common Stock | Grant | Acquire A | No | No | 2.54 | 1,574 | 4.00 k | 104,111 |
14 Jun 23 | LAB Standard BioTools | Common Stock | Grant | Acquire A | No | No | 0 | 26,376 | 0.00 | 102,537 |
14 Jun 23 | LAB Standard BioTools | Stock Option Common Stock | Grant | Acquire A | No | No | 2.18 | 35,380 | 77.13 k | 35,380 |
18 May 23 | RGEN Repligen | Common Stock | Grant | Acquire A | No | No | 0 | 686 | 0.00 | 2,297 |
18 May 23 | RGEN Repligen | Stock Option Common Stock | Grant | Acquire A | No | No | 156.63 | 1,487 | 232.91 k | 1,487 |
8 May 23 | RGEN Repligen | Common Stock | Buy | Acquire P | No | No | 156.18 | 500 | 78.09 k | 1,611 |
5 May 23 | RGEN Repligen | Common Stock | Buy | Acquire P | No | No | 159.19 | 500 | 79.60 k | 1,111 |
4 May 23 | RGEN Repligen | Common Stock | Buy | Acquire P | No | No | 161.15 | 500 | 80.58 k | 611 |